A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.
A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.
J Addict Med. 2013 Jul 26;
Wei X, Wang L, Wang X, Li J, Li H, Jia W
We analyzed a 6-year methadone maintenance treatment (MMT) retention rate in 8 MMT clinics in Xi’an and the factors that influenced the retention rate.We conducted a 6-year retrospective dynamic cohort study of 5849 eligible patients from 2006 to 2011. Participants were serially enrolled on the basis of opioid addiction, age, residence status, and civil capacity. Cumulative retention in treatment was calculated using survival analyses (life tables) on the basis of the number of days in MMT. We also used the Cox proportional hazard regression model to analyze the factors that may influence treatment retention.The MMT retention varied from a less than 1 month to a maximum of 71.2 months; the average dose was 48.76 ± 17.03 mg/d. The cumulative retention for 12, 24, 36, 48, 60, and 72 months after MMT initiation were 0.87, 0.76, 0.66, 0.57, 0.49, and 0.43, respectively. The MMT retention rate was significantly associated with factors that included the particular clinic for MMT, the year when the subject initiated MMT, average daily dose, hidden drug use, sex, age, length of drug abuse history, needle sharing, living arrangements, and employment status.The 6-year retention rates for MMT in the 8 clinics in Xi’an were higher than those reported in other studies of other clinics. High therapeutic doses (>60 mg/d) could reduce the risk of… Continue reading
Mechanisms of Resistance to Sorafenib and the Corresponding Strategies in Hepatocellular Carcinoma.
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma.
World J Hepatol. 2013 Jul 27; 5(7): 345-52
Zhai B, Sun XY
Sorafenib, the unique drug as first-line treatment for advanced hepatocellular carcinoma (HCC), has opened a… Continue reading
[Diagnosis and the Dynamics of Alcoholism in the Elderly.]
[Diagnosis and the dynamics of alcoholism in the elderly.]
Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(6 Vypusk 2 Alkogolizm): 43-46
Krivulin EN, Mingazov AK, Bokhan NA
A comprehensive clinical examination of 462 patients (391 men and 71… Continue reading
[The Relationship of Drug and Alcohol Addiction in Teenagers With the Character of Their Relations With Parents.]
[The relationship of drug and alcohol addiction in teenagers with the character of their relations with parents.]
Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(6 Vypusk 2 Alkogolizm): 72-74
Mendelevich VD, Makushina OP
An experimental-psychological study of 62… Continue reading
Repetitive Transcranial Magnetic Stimulation to Maintain Treatment Response to Electroconvulsive Therapy in Depression: A Case Series.
Repetitive transcranial magnetic stimulation to maintain treatment response to electroconvulsive therapy in depression: a case series.
Front Psychiatry. 2013; 4: 73
Noda Y, Daskalakis ZJ, Ramos C, Blumberger DM
Electroconvulsive therapy (ECT) is the most effective treatment for a… Continue reading
The Size, Burden and Cost of Disorders of the Brain in the UK.
The size, burden and cost of disorders of the brain in the UK.
J Psychopharmacol. 2013 Jul 24;
Fineberg NA, Haddad PM, Carpenter L, Gannon B, Sharpe R, Young AH, Joyce E, Rowe J, Wellsted D, Nutt D, Sahakian… Continue reading
Brain Damages in Ketamine Addicts as Revealed by Magnetic Resonance Imaging.
Brain damages in ketamine addicts as revealed by magnetic resonance imaging.
Front Neuroanat. 2013; 7: 23
Wang C, Zheng D, Xu J, Lam W, Yew DT
Ketamine, a known antagonist of N-methyl-D-aspartic (NMDA) glutamate receptors, had been used as… Continue reading